Skip to content Skip to menu

Industry welcomes Coalition manufacturing policy

Thursday, 22 August 2013

Media Release

 Medicines Australia has welcomed the Coalitions commitment to boosting manufacturing in Australia.

“The medicines industry welcomes any moves to reduce red-tape and boost exports and is ready to work with the Coalition to streamline regulation of our sector”, said Medicines Australia Chief Executive Brendan Shaw.

“As a knowledge based industry with over $4 billion in exports annually the medicines industry is well placed to contribute to Australian manufacturing into the future”.

“As we noted in our Election Priorities the strength of the Australian economy together with mountains of unharmonised and inefficient regulations makes it difficult for Australia to match it with global competitors”.

“However, Medicines Australia has been supportive of the R&D tax credit as a policy that has attracted investment to Australia and cautions that any changes to the policy must be carefully weighed to ensure they don’t discourage investment”.

-ENDS-

Contact Person:

Alex Chapman
Phone: (02) 8281 3204
Email:
alex@ogilvyprhealth.com

Top